Phytochemistry and cardiovascular protective effects of Huang‐Qi (Astragali Radix)

Medicinal Research Reviews - Tập 41 Số 4 - Trang 1999-2038 - 2021
Huifei Su1, Sharpkate Shaker1, Yi Kuang1, Meng Zhang1, Min Ye2,1, Xue Qiao1
1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China
2Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Peking University, Beijing, China

Tóm tắt

AbstractHuang‐Qi (Astragali Radix) is an herbal tonic widely used in China and many other countries. It is derived from the roots of Astragalus membranaceus and A. membranaceus var. mongholicus and shows potent cardiovascular protective effects. In this article, we comprehensively reviewed 189 small molecules isolated from the two Astragalus species and discussed the interspecies chemical differences. Moreover, we summarized the pharmacological activities and mechanisms of action of Huang‐Qi and its major bioactive compounds for the treatment of cardiovascular diseases. This review covers 171 references published between February 1983 and March 2020.

Từ khóa


Tài liệu tham khảo

10.1016/S1572-5995(02)80043-6

10.1002/cbdv.201100444

Amiri MS, 2020, Ethnobotanical knowledge of Astragalus spp.: the world's largest genus of vascular plants, Avicenna J Phytomed, 10, 128

Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China. Beijing: China Medical Science and Technology Press (CFDA);2015.

The United States Pharmacopeial Convention.U.S. Pharmacopeia/National Formulary. New York: The United States Pharmacopeial Convention;2017.

European Directorate for the Quality of Medicines & HealthCare. European Pharmacopoeia 8.0. Strasbourg;2017.

Japanese Pharmacopoeia Commission.The Japanese Pharmacopoeia. Ministry of Health and Welfare; 2016.

Korea Food and Drug Administration. Korean Pharmacopoeia. Seoul.

10.1002/ptr.5188

10.3390/ijms20061463

World Health Organization. Cardiovascular diseases (CVDs); 2017.https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 17 May 2017.

10.1016/j.biopha.2019.109094

10.1016/j.phrs.2018.11.006

10.1024/0040-5930/a000740

10.1016/j.biotechadv.2019.01.010

10.1371/journal.pone.0095004

Gao JM, 2019, Regularity of traditional Chinese medicine prescriptions for same treatment for cardiovascular and cerebrovascular diseases, China J Chin Mater Med. (Zhongguo Zhongyao Zazhi), 44, 193

10.5246/jcps.2013.02.031

10.1248/cpb.31.698

Cao ZZ, 1985, The structure of Astramembrannins, Acta Chim Sin (Huaxue Xuebao), 43, 581

Wang HK, 1987, Studies on chemical composition of Astragalus membranaceus var. mongholicus, Chin Tradit Herb Drugs. (Zhong Cao Yao), 18, 5

He ZQ, 1990, Isolation and identification of chemical constituents of Astragalus root, Acta Pharm Sin, 25, 694

10.1016/S0031-9422(00)89793-9

Cao ZZ, 1999, A new isoflavone glucoside from Astragalus membranaceus, Acta Pharm Sin, 34, 1

Bian YY, 2006, Studies on chemical constituents of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao, Chin Pharm J (Zhongguo Yaoxue Zazhi), 41, 1217

10.1248/cpb.56.105

Yang RP, 2008, The chemical constituents study of Astragalus membranceus (Fisch) Bge, Chin J Med Chem (Zhongguo Yaowu Huaxue Zazhi), 18, 457

Tu TZ, 2009, Study on constituents from the roots of Astragalus membranaceus (Fisch.) Bge. Hsiao, West China J Pharm Sci (Huaxi Yaoxue Zazhi), 24, 466

Wen YH, 2010, Chemical constituents of Astragalus membranaceus var. mongholicus, Pract Pharm Clin Rem (Shiyong Yaowu Yu Linchuang), 13, 115

10.1021/jf103610j

Zheng SS, 2011, Chemical constituents from the roots of Astragalus membranace (Fisch.) Bge. var. mongholicus (Bge.) Hisao, Acta Univ Tradit Med Sin Pharmacol Shanghai, 25, 89

Luo Z, 2012, Chemical constituents of Astragalus membranaceus var. mongholicus, Chin Tradit Herb Drugs. (Zhong Cao Yao), 43, 458

10.3390/molecules18043725

10.1002/cbdv.201400371

Li YX, 2017, Chemical constituents in roots of Astragalus membranaceus, Chin Tradit Herb Drugs (Zhong Cao Yao), 48, 2601

Wang X, 2017, Studies on astragalosides from Astragalus membranceus (Fisch) Bge, J Tianjin Med Univ (Tianjin Yike Daxue Xuebao), 23, 516

10.1248/cpb.31.709

Sun J, 2013, Chemical constituents from Astragalus membranaceus var. mongholicus, Drugs Clin (Xiandai Yaowu Yu Linchuang), 28, 138

Tian H, 2016, Chemical constituents of Astragalus membranaceus var. mongholicus, Chin J Exp Tradit Med Formulae (Zhongguo Shiyan Fangjixue Zazhi), 22, 70

Wang HK, 1989, Studies on chemical composition of Astragalus membranaceus var. mongholicus (II), Chin Tradit Herb Drugs (Zhong Cao Yao), 20, 6

10.3390/biom9100618

10.1021/np50075a009

10.1248/cpb.31.716

10.1248/cpb.45.359

10.1007/s11418-015-0959-8

10.1016/0031-9422(94)00833-F

Ma YL, 1993, A study on the constituents of stems and leaves of Astragalus membranaceus, Acta Bot Sin, 35, 480

10.1248/cpb.40.2230

Bi ZM, 2007, Flavonoids from the aerial parts of Astragalus mongholicus, Chin J Nat Med (Zhongguo Tianran Yaowu), 5, 263

10.1016/j.cclet.2007.03.025

10.1002/hlca.200800341

10.1002/hlca.201100174

10.1016/j.jchromb.2009.01.034

10.1016/j.fitote.2015.12.006

10.1016/j.tet.2016.09.034

Lee EJ, 2008, Phytochemical studies on Astragalus root (2)‐flavonoids and a lignan, Nat Prod Sci, 14, 131

Wang QH, 2014, Chemical constituents of roots of Astragalus membranaceus (Fisch) Bge. var. mongholicus (Bge) Hsiao, Chin Pharm J (Zhongguo Yaoxue Zazhi), 49, 357

10.3390/molecules21030354

Bian YY, 2008, Study on scavenging activities for superoxide anion radicals and structure‐activity relationship of flavonoids from Astragalus membranaceus (Fish.) Bge. var. mongholicus (Bge.) Hsiao, Chin Pharm J, 43, 256

Wang ZB, 2017, Flavonoids from the leaves of Astragalus membranaceus, Chin Tradit Pat Med (Zhong Cheng Yao), 39, 1634

Ma YL, 1991, A study on the constituents of stems and leaves of Astragalus membranaceus B, J Shenyang Coll Pharm, 8, 121

10.1007/s00706-015-1473-0

Wang ZX, 1983, Study on chemical composition of Astragali Radix, Chin Tradit Herb Drugs (Zhong Cao Yao), 14, 1

Song CQ, 1997, Isoflavones from Astragalus membranaceus, Acta Bot Sin, 39, 764

Ma XF, 2005, Flavonoid constituents of Astragalus membranaceus var. mongholicus, Chin Tradit Herb Drugs (Zhong Cao Yao), 36, 1293

Zhang YZ, 2012, Isoflavonoids from roots of Astragalus membranaceus var. mongholicus, China J Chin Mater Med (Zhongguo Zhongyao Zazhi), 37, 3243

Wang X, 2016, Studies on flavonoids and related constituents from Astragalus membranceus (Fisch) Bge, J Tianjin Med Univ (Tianjin Yike Daxue Xuebao), 22, 409

Li RF, 2007, Chemical constituents of Astragalus membranaceus Bge. var. mongholicus (Bge.) Hsiao, J Shenyang Pharm Univ (Shenyang Yaoke Daxue Xuebao), 24, 20

10.1016/j.fitote.2007.04.007

10.1016/0031-9422(91)85143-N

Song CQ, 1997, Pterocarpans and isoflavanes from Astragalus membranaceus (FISCH.) BUNGE, Acta Bot Sin, 39, 1169

10.1016/j.chroma.2003.10.014

10.1016/j.molstruc.2014.08.025

Song CQ, 1997, Antimicrobial isoflavans from Astragalus membranaceus (FISCH.) BUNGE, Acta Bot Sin, 39, 486

10.1016/j.molstruc.2014.06.020

He K, 1988, Progress in recent years on the chemical constituents of Astragali Radix and its related plants, Acta Chim Sin, 23, 873

10.1016/j.jpha.2019.06.002

10.1016/j.jpba.2018.12.015

10.2174/092986706778521869

10.1039/C4NP00117F

10.1142/S0192415X20500020

10.3109/13880209.2010.504732

The Plant Index of China.Astragalus membranaceusvar.mongholicus(Bunge) P.K. Hsiao; 1993.http://www.iplant.cn/info/Astragalus%20membranaceus%20var.%20mongholicus?t=z. Accessed March 15 2020.

Qian D, 2009, A taxonomic study on the original plant of Radix Astragali, Acta Pharm Sin (Yaoxue Xuebao), 44, 1429

Zhao YZ, 2006, Taxonomy and floristic geographical distribution of the Chinese medicinal Huangqi, Bull Bot Res (Zhiwu Yanjiu), 26, 532

10.3390/molecules24224064

10.1016/j.amjmed.2018.03.032

Li Ping, 2007, Observation on effect of astragalus pretreatment on the myocardial lipid peroxidation and ultrastructure in rats with ischemia reperfusion, Chin Hosp Pharm J (Zhongguo Yiyuan Yaoxue Zazhi), 27, 913

10.1038/s41401-018-0082-y

10.1002/ptr.5297

10.1248/bpb.b18-00854

10.1139/cjpp-2015-0457

10.1159/000121335

10.1002/ptr.2332

10.1142/S0192415X09007028

10.1016/j.jep.2013.07.036

10.1002/ptr.2575

10.1142/S0192415X0600448X

10.18632/oncotarget.13596

10.1055/s-2005-873126

10.1016/j.ejphar.2007.04.007

10.3389/fphar.2018.01163

10.1159/000493827

10.1016/j.ejphar.2019.172490

10.3109/08923973.2015.1080266

10.3892/mmr.2015.3400

Ruan T, 2015, Effects of Astragalus membranaous on the proliferation and transforming growth factor β1 production of cardiac fibroblasts, J Clin Pediatr (Linchuang Erke Zazhi), 33, 284

10.1016/j.phymed.2017.04.002

10.1016/j.jep.2019.112404

Li JS, 2016, Influence of astragaloside IV on myocardial fibrosis in rats, Chin J Exp Tradit Med Formulae, 32, 42

10.3892/mmr.2017.7676

10.1016/j.ejphar.2011.02.040

10.1016/j.ejphar.2018.06.016

10.3892/mmr.2017.6220

10.1016/j.etap.2015.03.014

10.1016/j.intimp.2016.06.014

10.1016/j.etap.2014.05.008

10.1016/j.jep.2013.10.017

10.1371/journal.pone.0118759

10.1142/S0192415X06004028

Deng W, 2004, Effect of Astragalus membranaceus on myocardial mitochondrial structure and ionic pump functions in mice infected with CVB3, Med J Wuhan Univ (Wuhan Daxue Xuebao, Yixueban), 25, 257

10.1538/expanim.19-0037

10.1080/10286020412331286506

Wang MH, 2007, The antioxidant effect of Astragaloside on coxsackievirus B3‐induced muring myocarditis, J Clin Pediatr (Linchuang Erke Zazhi), 25, 825

Shen E, 2008, Association of attenuating left ventricular remodeling in murine dilated cardiomyopathy with phosphorylation of p38MAPK after interference by astragaloside, Chin J Pathophysiol (Zhongguo Bingli Shengli Zazhi), 24, 64

Yu XH, 2005, Effect of astragaloside on gene expression of coxsackie‐adenovirus receptor in viral myocarditic mice, J Appl Clin Pediatr (Shiyong Erke Linchuang Zazhi), 20, 215

Yu XH, 2005, Effect of astragaloside on myocardial cathepsin B mRNA expression in viral myocarditic mice, J Appl Clin Pediatr (Shiyong Erke Linchuang Zazhi), 20, 622

Yu XH, 2006, Effect of astragaloside on the expression of cathepsin L in the myocardium with viral myocarditis, J Clin Pediatr (Linchuang Erke Zazhi), 24, 57

Wang AQ, 2006, Effect of astragaloside on expression of nerve growth factor in the myocardium with viral myocarditis, J Appl Clin Pediatr (Shiyong Erke Linchuang Zazhi), 21, 14

10.1248/bpb.32.68

10.1016/j.jep.2019.111857

10.1177/147323000703500615

10.1016/j.jdiacomp.2008.12.003

10.1371/journal.pone.0045541

10.3892/mmr.2017.6515

You LZ, 2019, Astragaloside IV prevents high glucose‑induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells, Mol Med Rep, 19, 1603

10.1016/j.lfs.2018.07.053

10.3892/etm.2014.1905

10.3892/etm.2016.3514

Liang LS, 2006, Protective effect of astragalus flavone of Gansu on endothelial cells apoptosis induced by angiotensin II in culture, Chin Pharm Bull., 22, 1505

Li XL, 2011, Protective effects of four kinds of flavonoids of Astragalus membranaceus on the endothelial function, J Lanzhou Univ (Med Sci), 37, 1

10.1016/j.ejphar.2003.09.007

10.1186/s12906-015-0839-5

10.1016/j.ejphar.2005.08.063

Chen ZK, 2003, Effect of Astragalus membranaceus on baroreflex sensitivity in spontaneously hypertensive rats, China J Chin Mater Med (Zhongguo Zhongyao Zazhi), 28, 155

10.1016/j.jep.2020.112724

10.1248/bpb.28.1450

10.1111/j.1440-1681.2007.04564.x

10.1055/s-2006-931572

10.1159/000489958

10.1016/j.jnutbio.2009.03.010

10.1111/j.1745-7254.2006.00349.x

10.3892/etm.2017.4739

10.1016/j.vph.2006.11.001

10.1248/bpb.33.641

10.1155/2012/282383

Wang DQ, 2003, Effects of total flavonoids of astragalus on early atherosclerosis in rabbits with diet‐induced hypercholesterolemia, Chin Pharmacol Bull (Zhongguo Yaolixue Tongbao), 19, 637

Qin HW, 2015, Effects of Astragaloside IV on the SDF‐1/CXCR4 expression in atherosclerosis of apoE−/− mice induced by hyperlipaemia, J Evidence‐Based Complementary Altern Med, 2015, 385154

10.7150/thno.38115

Zhang L, 2011, Astragalus membranaceus extract promotes neovascularisation by VEGF pathway in rat model of ischemic injury, Pharmazie, 66, 144

10.1124/jpet.111.180992

10.1177/1089253211436350

10.1093/cvr/cvaa324

10.1016/j.yjmcc.2016.06.001

10.1038/nrcardio.2015.108

10.1007/s00125-017-4390-4

10.1038/74651

10.1097/CRD.0b013e3181c307b7

10.1177/1179573520962230

10.1038/nature10146

10.1007/s10456-016-9514-9